Sunscreen Stability Testing: What the FDA OTC Monograph Actually Requires — and Where Most Brands Fall Short

Avobenzone, the broad-spectrum UV-A filter found in the majority of US chemical sunscreens, begins degrading the moment it does its job. Expose it to UV radiation without a photostabilizer and you can lose 36–47% of its active concentration within two hours of simulated solar exposure. That’s not a fringe finding from an obscure paper — it’s well-documented photochemistry that any formulator working with this ingredient has had to reckon with. And yet, we still regularly receive samples where the photostability study was either never run or executed under conditions that wouldn’t come close to satisfying what FDA expects.

That gap between what the science demands and what brands actually test for is exactly where recalls, warning letters, and shelf-life failures originate.

Why the US Sunscreen Market Is Testing With One Hand Tied

Sunscreens sold in the United States are regulated as OTC drugs under the FDA sunscreen monograph — not as cosmetics, which is a distinction that catches brands off guard more often than it should. Under the OTC Drug Monograph Reform enacted through the CARES Act of 2020, FDA gained authority to issue final administrative orders for monograph conditions, replacing what had been a decades-long rulemaking process.

The current operative framework traces back to FDA’s 2019 Proposed Rule (84 FR 6204), which evaluated 16 active sunscreen ingredients for their Generally Recognized as Safe and Effective (GRASE) status. The result was uncomfortable for most brands: only zinc oxide and titanium dioxide landed in Category I (GRASE). PABA and trolamine salicylate were placed in Category II (not GRASE). The remaining 12 — including avobenzone, octinoxate, oxybenzone, homosalate, and octocrylene — were assigned to Category IIISE. That designation means FDA found existing data insufficient to establish GRASE status, and manufacturers wishing to continue marketing those ingredients bear the burden of generating the missing safety and efficacy data themselves.

That data request includes, explicitly, stability information. FDA expects that any sunscreen product making an SPF claim can demonstrate through controlled stability testing that the labeled SPF is maintained through the product’s stated expiration date. For most commercial sunscreens, that’s a 36-month durability claim — which means your stability program needs to support three years.

Meanwhile, the EU has already authorized more photostable broad-spectrum UV filters like bemotrizinol (Tinosorb S) and bisoctrizole (Tinosorb M). US brands are formulating with older chemistry and a more restrictive ingredient toolkit. That’s precisely why photostability testing matters more here, not less.

ICH Q1B Photostability: The Study Most Brands Underestimate

ICH Q1B — the International Council for Harmonisation’s guideline on photostability testing of new drug substances and products — defines the standard approach for evaluating sunscreen photostability. The guideline requires samples to be exposed to a minimum of 1.2 million lux hours of visible light and 200 Wh/m² of UV radiation, using a D65 or ID65 light source (typically a filtered xenon arc lamp).

Samples are tested across three configurations: unpackaged (the formulation directly), in immediate pack (the bottle or tube), and in market pack (the labeled retail unit as a consumer would receive it). For sunscreens, that threefold setup matters enormously. A formula that passes photostability in an amber or opaque HDPE container may fail completely when tested in the clear glass jar that marketing prefers.

This is actually one of the most operationally valuable pieces of information a photostability study produces: it tells you whether your packaging decision is contributing to product failure before you’ve committed to tooling costs.

On the assay side, we’re measuring the concentration of each active ingredient before and after light exposure. For avobenzone specifically, USP provides an HPLC-based assay method that resolves the parent compound from its photodegradation products. A passing result typically requires that assay values remain within 90–110% of the labeled amount at study end. In practice, we’ve seen avobenzone samples where the final concentration was below 70% of initial — not under accelerated thermal conditions, but from photostability exposure alone.

What a Compliant Stability Protocol Looks Like for a 3-Year Expiration Claim

A stability program supporting a 36-month expiration date for a US OTC sunscreen should include, at minimum:

• Real-time storage: 25°C ± 2°C / 60% RH ± 5%, with timepoints at T=0, 3, 6, 9, 12, 18, 24, and 36 months
• Accelerated storage: 40°C ± 2°C / 75% RH ± 5%, with timepoints at T=0, 1, 3, and 6 months (six months of accelerated data can provisionally support a 24-month shelf-life claim while real-time data accumulates)
• Photostability study: Per ICH Q1B, initiated at T=0 in parallel with real-time and accelerated chambers

At each timepoint, the testing panel should cover: SPF assay (in vitro or in vivo per 21 CFR 201.327), active ingredient assay by HPLC, pH, viscosity, appearance and phase stability (visual and centrifuge assessment), and microbial limits per USP <61>/<62> for OTC drug products.

Freeze-thaw cycling — typically 5 cycles of –4°C to 40°C — is standard for emulsion-based sunscreens, and this is where mineral sunscreen formulas most often show early signs of trouble. Zinc oxide and titanium dioxide suspensions are vulnerable to particle aggregation and phase separation: by cycle 3 in a poorly stabilized emulsion, you can have visible sedimentation that directly predicts uneven UV protection distribution and failed SPF values.

One parameter brands sometimes omit is in-use stability — testing from a container that’s been opened and repeatedly accessed, simulating consumer handling over weeks of use. For tubes and pumps, this is lower priority. For jars and flip-top caps, it’s worth incorporating, because microbial contamination and oxidative degradation can both accelerate with repeated air exposure.

The Failure Patterns We See Most Often

A few patterns appear consistently when brands send stability samples for troubleshooting after unexpected failures.

Avobenzone without an adequate photostabilizer loading. Octocrylene is the most common co-formulant used to photostabilize avobenzone in US products, but cost pressures sometimes lead to reduced octocrylene at less than 2.5% w/w. The consequence is faster avobenzone degradation and a meaningful SPF shift at the 6-month accelerated timepoint. If your formula relies on 3% avobenzone with minimal stabilizer support, budget for shorter monitoring intervals and expect scrutiny at accelerated T=6.

Fragrance-induced instability in SPF moisturizers. Some fragrance components are photoreactive or chemically reactive toward sunscreen actives. Citrus-derived constituents — limonene, linalool — can accelerate oxidative degradation of certain UV filters. We’ve had 12-month accelerated samples of SPF moisturizers where the SPF dropped more than 20% relative to T=0, and the root cause traced back to fragrance interaction rather than inherent active ingredient instability.

Clear packaging around photosensitive formulas. Avobenzone-containing sunscreens in clear PET or glass with no UV-blocking additive in the packaging material continue to show up in our stability queue. Under ICH Q1B conditions — and in actual sunlit retail shelf environments — these products accumulate meaningful active degradation before the consumer has opened the bottle.

The One Step That Saves the Most Development Time

Run your photostability study before you finalize your packaging specification. This is the highest-leverage intervention available in sunscreen development, and it’s chronically delayed in brand timelines because packaging decisions tend to run in parallel with formulation finalization rather than sequentially after it.

A photostability study takes approximately 2–4 weeks to complete at an equipped cosmetic testing laboratory, including sample prep, chamber exposure, and assay turnaround. That timeline is trivial relative to the cost of retooling packaging post-failure, or the business cost of launching a product that misses its 12-month real-time SPF specification.

If you’re formulating with avobenzone, test your photostabilizer system in the actual packaging you intend to sell — not surrogate vessels. If your formula is mineral-based, the photodegradation risk is lower, but your emulsion stress testing and particle size characterization need to be thorough. Zinc oxide and titanium dioxide don’t degrade optically, but they aggregate and sediment in poorly designed emulsions, and that failure mode is just as damaging to your SPF claim.

For stability data that will hold up to FDA review — whether in response to a Category IIISE data request or in support of a broader regulatory submission — the study needs to be executed and documented at an ISO 17025 accredited cosmetic testing laboratory. Accreditation provides the methodological traceability and chain of custody that gives your data defensibility when it counts.

FDA scrutiny of the sunscreen monograph is not receding. Brands with proactive, well-documented stability packages on file will be substantially better positioned than those generating data reactively in response to an agency request.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• FDA OTC Drug Monograph Compliance Consulting — Aurora TIC provides regulatory consulting on CARES Act OTC monograph reform, FDA audit preparation, and documentation strategy for drug product submissions.
• Sunscreen Active Ingredient Raw Material Testing & COA Verification — Ayah Labs offers independent assay and identity testing for avobenzone, zinc oxide, titanium dioxide, and other sunscreen raw materials before they enter your formula.